Board of Directors

Mr. Gastle is the founder of Microbix and has served as a Director since its inception. He is the Chairman of the Board. Mr. Gastle is primarily responsible for setting the strategic direction of the Company and is the principal architect of the Company's business development activities.

Dr. Cochran has been serving on the board since 1990 and was appointed Chief Business Officer of Microbix in May of 2008. Dr. Cochran’s professional experience spans all levels of the drug discovery and development value chain including operational and executive roles in venture capital, pharmaceutical and biotechnology industries. His previous experience includes Bayer Pharmaceuticals, last serving as Vice President of Business Development, Biotechnology, in Berkeley, California.

Mr. Renner, CEO and partner in Zydus Pharmaceuticals, Pennington N.J., has over 25 years experience in the pharmaceutical industry. He has had a successful career leading businesses with many drug approvals in the US.

Mr. Marino has over 30 years of experience in corporate legal roles and executive management functions, with particular emphasis in transaction based activities related to domestic and international corporate development. He also has considerable experience in conflict resolution and litigation management.

Mr. Pollock has over 20 years of experience in the Canadian Packaged Goods industry and currently serves as the Senior Vice President, Marketing and Innovation for Maple Leaf Consumer Foods. He previously managed the consumer programs for some of the world's biggest brands at the HJ Heinz Company and Campbell Soup and assumed senior Marketing roles at HMV North America and Cott Beverages.

Mr. Embro-Pantalony is Managing Director of StratPath Group working with life science companies to execute strategy, enhance governance processes, raise financing, and pursue business development opportunities. He has held executive positions in both the healthcare and agriculture sectors, including VP Finance & CFO of Novopharm Limited; VP, Information Technology & CIO of Bayer Inc., VP, Finance & Administration of Bayer Healthcare; and CFO of Zeneca Pharma Inc.

Dr. Blecher is the founder of several start-up biotechnology ventures, the last of which, Sequent Biotechnologies, Inc., was purchased by Microbix in 2005. He practices Emergency Medicine at Lakeridge Health Hospital, and chronic pain medicine at CPM Centres for Pain Management, the largest network of pain management clinics in Canada, currently with nine clinics, where he is Medical Director of Interventional Training.